Home › Trial NCT05443412
Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection
- Trial IDNCT05443412
- StatusRecruiting
- PhaseN/A
- Study typeObservational
- SponsorChinese University of Hong Kong
- Enrollment510
- Start date2023-08-01
- ConditionsProstate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.